About VistaPath Biosystems
VistaPath Biosystems is a private company based in Cambridge, Massachusetts. It has reported $13,653,931 raised in six offerings on Form D since July 2019. Its chief executive is Timothy Spong.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 22, 2023 | Jul 7, 2023 | $4,442,495of $5.6M target | 5 | $888K | EquityRule 506(b) | Form D ↗ |
| Jan 20, 2023 | Jan 20, 2023 | $1,000,000of $4.0M target | 1 | $1.0M | Simple Agreement for Future EquityRule 506(b) | Form D ↗ |
| Jan 27, 2022 | Feb 9, 2022amended Jun 21, 2022 | $7,416,436fully sold | 35 | $211K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| May 6, 2021 | May 20, 2021 | $100,000of $1.5M target | 4 | $25,000 | Convertible Promissory NoteRule 506(b) | Form D ↗ |
| Mar 18, 2020 | Sep 11, 2020amended Sep 23, 2020 | $470,000fully sold | 9 | $52,222 | Convertible Promissory NoteRule 506(b) | Form D/A ↗1 earlier filing |
| Jun 24, 2019 | Jul 11, 2019 | $225,000of $350K target | 4 | $56,250 | Convertible Promissory NoteRule 506(b) | Form D ↗ |
| Total, six offerings | $13,653,931 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on VistaPath Biosystems's Form D filed Jul 7, 2023.
BB
Benjamin Burley
Executive officer and director
TS
Timothy Spong
Chief Executive Officer and director